Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Bullboard Posts
Comment by billy4325on Nov 01, 2018 7:32pm
96 Views
Post# 28911438

RE:RE:RE:RE:CIBC support

RE:RE:RE:RE:CIBC support
oats wrote: Billybud,

The progress that this company has made, in the past 4 years specifically, is huge.  You clearly do not get or understand what they are doing, if you did, you would not make such ridiculous statements with regards to getting into MJ.  

Do you understand what kind of effort and cost would be invovled in this process?  Clearly, you do not.

If you decided to make this move, where does that put everything else that is on the table?  In, the back seat, that is exactly what you are saying.  You are nothing but another "flavor of the day jumper" because you F'd up and paid too much for the stock.  It is that simple.  If you cared or understood what they actually are trying to accomplish, you would be averaging down and taking advantage of this opportunity.

The company has a business plan.  They are following it and are clearly making progress, your problem, along with others, is that you are looking at the immediate short term rather that what the company is trying to buid over the long term and, in fact, is putting the bricks in place, one by one, to get this to a revenue generation standpoint.  Anyone who has any business sense could see this without queston.  Those who are zero'd in on the stock price daily, like you are, wanting that boost so you can somehow get whole again, are pulling their hair out in frustration.  Since that is the case, you should be selling now to get rid of the frustration.  On the other hand, there are those, like the CIBC buyer who are looking at this as an opportunity.  You have already mentioned the 1000% gain opportunity lost so this is your "give away" per your underlying true feeling.  If you were not prepared to let this move forward and fully transition to a BioPharma company, you should not have bought shares in the first place.  Everyone needs to know what they are buying.  Don't blame the company for your bad decision, when things were going south, you could have called the company to ask WTF?  Did you?

I can tell you with a pretty high level of certainty that Ceapro has a much much better risk/reward opportunity that most of the MJ stocks out there, the MJ correction is not over.  The numbers that I provided in the previous post are proof positive of what the banks think of this sector at this time. Big time overvalued. 


Oats,
 
The company has made some progress however it has been well short of expectations.  Also the company has had significant declines in existing revenue streams.  I don't think I need to go into detail about this, as it has been discussed many times already on this board.
 
You brought MJ up, indicating that Gilles had said they may get into the sector when the time is right.  I was just saying that the right time has already passed.  The percentages I used were not literal, I wanted to illustrate that any over-valuation of other pot stocks is irrelevant.  If getting into the extraction of MJ is a very profitable endeavour (which Gilles also claims CZO to be the best at), it would probably be something they should have gotten into at the correct time.  Your post seems to indicate you think this as well, however you are saying that it should be done later when there are many established companies and consolidation.  I think they should have gotten in when they were "better than anyone" at it and there was much less competition.  Also any "overvaluation" would have actually been a benefit to CZO if they had to raise capital for costs.
 
Your next paragarph is just a bunch of ad hominems.  Nothing I can really say about that.
 
Yes I am aware of their business plan.  Again, the problem is the poor execution of their business plan.  Sales of existing products have decreased significantly.  Still no deals for PGX despite getting the European patent.  Still running both plants even though the transition which should have finished early 2017.  The cholesterol study was finally approved, too bad it was supposed to have started Q4 2016 - who knows how long (or if at all) it will take to get to turn it into a viable product for the market.
 
I couldn't care less about the daily price fluctuations, so I'm not sure why you keep bringing this point up.   To be very clear for you, I am concerned about the company's poor execution and consistently missing expectations for the past 3 years.  Also yes I have contacted IR many times, I either get a generic reply which doesn't answer my question or IR doesn't reply at all.  
 
I agree with you that the MJ sector is over-valued, however as I have stated before this isn't relevant in whether it would be good for CZO to provide extraction services for the industry.
 
Bullboard Posts